The UK’s Best Hope for Tech Prowess Sits in Its Labs, Not Apps or AI
World-renowned academic institutions and a national health care system are a big draw for biotech and life sciences industries.
World-renowned academic institutions and a national health care system are a big draw for biotech and life sciences industries.
Speculation that the Bank of Japan will make some kind of policy move this month continues to build with the weak yen, higher bond yields and stronger-than-expected inflation fueling the market chatter.
Switzerland’s right-wing People’s Party scored one of its best results ever in national elections, reaping the rewards of a campaign that leveraged concerns over immigration.
Game platforms including Microsoft Corp.’s Xbox and Sony Group Corp.’s PlayStation will be “the most clear-cut beneficiaries of AI adoption in the game industry,” according to Morgan Stanley.
Japanese Prime Minister Fumio Kishida underscored his plan to return some tax revenues to the public, fund more handouts for those on low incomes and extend energy subsidies in a speech a day after his party lost a special election.
Argentina’s election will be settled in a presidential runoff between Economy Minister Sergio Massa, who defied expectations to snatch the lead in Sunday’s election, and libertarian outsider Javier Milei. It’s a politically polarizing scenario that investors had feared most.
Australia’s Prime Minister Anthony Albanese will visit China next month in the latest sign of thawing ties after a years-long dispute, with the two sides signaling a deal toward ending Chinese tariffs on Australian wine exports.
Vedanta Ltd. may lose its third chief financial officer in as many years just as the mining conglomerate controlled by billionaire Anil Agarwal heads into an ambitious restructuring of its businesses, according to people familiar with the matter.
About 40% of issuers in this crucial area of corporate finance are yet to price a new deal this year. That’s an unwelcome signal for Wall Street — and business.
UK Chancellor Jeremy Hunt is facing a pension industry backlash over plans to push more savings into risky unlisted assets like private equity and public building projects.